HEMJENA Trademark

Trademark Overview

On Friday, February 26, 2021, a trademark application was filed for HEMJENA with the United States Patent and Trademark Office. The USPTO has given the HEMJENA trademark a serial number of 79311185. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Bluebird Bio (UK) Ltd.. The HEMJENA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
hemjena

General Information

Serial Number79311185
Word MarkHEMJENA
Filing DateFriday, February 26, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6829674
Registration DateTuesday, August 30, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
Translation of Words in MarkThe wording "HEMJENA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 21, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namebluebird bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS
Party Namebluebird bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressUS
Party NameBluebird Bio (UK) Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, May 20, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 25, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, September 21, 2021ASSIGNED TO EXAMINER
Tuesday, September 21, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 4, 2021REFUSAL PROCESSED BY MPU
Monday, October 4, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, October 30, 2021REFUSAL PROCESSED BY IB
Saturday, November 6, 2021CHANGE OF OWNER RECEIVED FROM IB
Saturday, December 18, 2021NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 31, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, May 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, November 30, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Thursday, December 8, 2022FINAL DISPOSITION PROCESSED
Friday, December 9, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, January 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

hemjena treatment sickle cell disease namely therapy preparations substances gene pharmaceutical